Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Yan Dora Zhang
(Department of Statistics and Actuarial Science, Faculty of Science, The University of Hong Kong)
Amber N. Hurson
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Haoyu Zhang
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Parichoy Pal Choudhury
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Douglas F. Easton
(Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Roger L. Milne
(Cancer Epidemiology Division, Cancer Council Victoria)
Jacques Simard
(Centre Hospitalier Universitaire de Québec–Université Laval Research Center)
Per Hall
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet)
Kyriaki Michailidou
(Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Joe Dennis
(Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Marjanka K. Schmidt
(Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital)
Jenny Chang-Claude
(Division of Cancer Epidemiology, German Cancer Research Center (DKFZ))
Puya Gharahkhani
(Statistical Genetics, QIMR Berghofer Medical Research Institute)
David Whiteman
(Cancer Control, QIMR Berghofer Medical Research Institute)
Peter T. Campbell
(Behavioral and Epidemiology Research Group, American Cancer Society)
Michael Hoffmeister
(Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ))
Mark Jenkins
(Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne)
Ulrike Peters
(Public Health Sciences Division, Fred Hutchinson Cancer Research Center)
Li Hsu
(Public Health Sciences Division, Fred Hutchinson Cancer Research Center)
Stephen B. Gruber
(Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California)
Graham Casey
(Department of Public Health Sciences, Center for Public Health Genomics, University of Virginia)
Stephanie L. Schmit
(Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institution)
Tracy A. O’Mara
(Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute)
Amanda B. Spurdle
(Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute)
Deborah J. Thompson
(Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Ian Tomlinson
(Institute of Cancer and Genomic Sciences, University of Birmingham)
Immaculata De Vivo
(Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School)
Maria Teresa Landi
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Matthew H. Law
(Statistical Genetics, QIMR Berghofer Medical Research Institute)
Mark M. Iles
(Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds)
Florence Demenais
(Université de Paris, UMRS-1124, Institut National de la Santé et de la Recherche Médicale (INSERM))
Rajiv Kumar
(Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ))
Stuart MacGregor
(Statistical Genetics, QIMR Berghofer Medical Research Institute)
D. Timothy Bishop
(Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds)
Sarah V. Ward
(Centre for Genetic Origins of Health and Disease, School of Biomedical Sciences, The University of Western Australia)
Melissa L. Bondy
(Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine)
Richard Houlston
(Division of Genetics and Epidemiology, The Institute of Cancer Research)
John K. Wiencke
(Department of Neurological Surgery, School of Medicine, University of California, San Francisco)
Beatrice Melin
(Department of Radiation Sciences Oncology, Umeå University)
Jill Barnholtz-Sloan
(Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine)
Ben Kinnersley
(Division of Genetics and Epidemiology, The Institute of Cancer Research)
Margaret R. Wrensch
(Department of Neurological Surgery, School of Medicine, University of California, San Francisco)
Christopher I. Amos
(Institute for Clinical and Translational Research, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine)
Rayjean J. Hung
(Lunenfeld-Tanenbuaum Research Institute, Sinai Health System)
Paul Brennan
(International Agency for Research on Cancer, World Health Organization)
James McKay
(International Agency for Research on Cancer, World Health Organization)
Neil E. Caporaso
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Sonja I. Berndt
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Brenda M. Birmann
(Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School)
Nicola J. Camp
(Division of Hematology and Hematological Malignancies, University of Utah School of Medicine)
Peter Kraft
(Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health)
Nathaniel Rothman
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Susan L. Slager
(Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic)
Andrew Berchuck
(Department of Gynecologic Oncology, Duke University Medical Center)
Paul D. P. Pharoah
(Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Thomas A. Sellers
(Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institution)
Simon A. Gayther
(Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center)
Celeste L. Pearce
(Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California)
Ellen L. Goode
(Division of Epidemiology, Department of Health Science Research, Mayo Clinic)
Joellen M. Schildkraut
(Rollins School of Public Health, Emory University)
Kirsten B. Moysich
(Division of Cancer Prevention and Control, Roswell Park Cancer Institute)
Laufey T. Amundadottir
(Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health)
Eric J. Jacobs
(Behavioral and Epidemiology Research Group, American Cancer Society)
Alison P. Klein
(Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine)
Gloria M. Petersen
(Division of Epidemiology, Department of Health Science Research, Mayo Clinic)
Harvey A. Risch
(Chronic Disease Epidemiology, Yale School of Medicine)
Rachel Z. Stolzenberg-Solomon
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Brian M. Wolpin
(Department of Medical Oncology, Dana-Farber Cancer Institute)
Donghui Li
(Division of Cancer Medicine, GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center)
Rosalind A. Eeles
(Division of Genetics and Epidemiology, The Institute of Cancer Research)
Christopher A. Haiman
(Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California)
Zsofia Kote-Jarai
(Division of Genetics and Epidemiology, The Institute of Cancer Research)
Fredrick R. Schumacher
(Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine)
Ali Amin Al Olama
(Strangeways Research Laboratory, Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge)
Mark P. Purdue
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Ghislaine Scelo
(International Agency for Research on Cancer, World Health Organization)
Marlene D. Dalgaard
(Department of Growth and Reproduction, Copenhagen University Hospital (Rigshospitalet))
Mark H. Greene
(Clinical Genetics Branch, Division of Cancer Genetics and Epidemiology, National Cancer Institute)
Tom Grotmol
(Cancer Registry of Norway)
Peter A. Kanetsky
(Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institution)
Katherine A. McGlynn
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Katherine L. Nathanson
(Division of Translational Health and Human Genetics, Department of Medicine, University of Pennsylvania)
Clare Turnbull
(Division of Genetics and Epidemiology, The Institute of Cancer Research)
Fredrik Wiklund
(Department of Medical Epidemiology and Biostatistics, Karolinska Institutet)
Breast Cancer Association Consortium (BCAC)
Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)
Colon Cancer Family Registry (CCFR)
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT)
Endometrial Cancer Association Consortium (ECAC)
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
Melanoma Genetics Consortium (GenoMEL)
Glioma International Case-Control Study (GICC)
International Lung Cancer Consortium (ILCCO)
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium
International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph)
Ovarian Cancer Association Consortium (OCAC)
Oral Cancer GWAS
Pancreatic Cancer Case-Control Consortium (PanC4)
Pancreatic Cancer Cohort Consortium (PanScan)
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
Renal Cancer GWAS
Testicular Cancer Consortium (TECAC)
Stephen J. Chanock
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Nilanjan Chatterjee
(Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University)
Montserrat Garcia-Closas
(Division of Cancer Epidemiology and Genetics, National Cancer Institute)
Journal: Nature Communications
•
• Nature Portfolio
• ISSN:
2041-1723
Abstract
In cancer many gene variants may contribute to disease etiology, but the impact of a given gene variant may have varied effect size. Here, the authors analyse summary statistics of genome-wide association studies from fourteen cancers, and show the utility of polygenic risk scores may vary depending on cancer type.
Subjects & Keywords
How to Cite this Article
Yan Dora Zhang, Amber N. Hurson, Haoyu Zhang, et al. (2020). "Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers". Nature Communications. https://doi.org/10.1038/s41467-020-16483-3